Literature DB >> 16741887

Incidence of Guillain-Barré syndrome among patients with Campylobacter infection: a general practice research database study.

Clarence C Tam1, Laura C Rodrigues, Irene Petersen, Amir Islam, Andrew Hayward, Sarah J O'Brien.   

Abstract

The association between Campylobacter infection and subsequent Guillain-Barré syndrome (GBS) has been well documented. To date, however, there exists no direct estimate of the incidence of GBS among patients with Campylobacter infection. Using the General Practice Research Database, we estimate the incidence of GBS in a cohort of patients presenting with Campylobacter enteritis to be 1.17/1000 person-years, a rate 77 times greater than that in the general population. The probability that an individual who develops Campylobacter enteritis will also develop GBS during the subsequent 2-month period is <2/10,000.

Entities:  

Mesh:

Year:  2006        PMID: 16741887     DOI: 10.1086/504294

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  37 in total

1.  Neurologic symptoms associated with raising poultry and swine among participants in the Agricultural Health Study.

Authors:  Meghan F Davis; Freya Kamel; Jane A Hoppin; Michael C R Alavanja; Laura Beane Freeman; Gregory C Gray; Kenrad Nelson; Ellen Silbergeld
Journal:  J Occup Environ Med       Date:  2011-02       Impact factor: 2.162

2.  Novel insight in the association between salmonellosis or campylobacteriosis and chronic illness, and the role of host genetics in susceptibility to these diseases.

Authors:  Y Doorduyn; W Van Pelt; C L E Siezen; F Van Der Horst; Y T H P Van Duynhoven; B Hoebee; R Janssen
Journal:  Epidemiol Infect       Date:  2007-12-07       Impact factor: 2.451

Review 3.  Minding the gap: The impact of B-cell tolerance on the microbial antibody repertoire.

Authors:  Joel Finney; Akiko Watanabe; Garnett Kelsoe; Masayuki Kuraoka
Journal:  Immunol Rev       Date:  2019-09-27       Impact factor: 12.988

Review 4.  Guillain-Barré syndrome: pathogenesis, diagnosis, treatment and prognosis.

Authors:  Bianca van den Berg; Christa Walgaard; Judith Drenthen; Christiaan Fokke; Bart C Jacobs; Pieter A van Doorn
Journal:  Nat Rev Neurol       Date:  2014-07-15       Impact factor: 42.937

5.  Neurologic symptoms associated with cattle farming in the agricultural health study.

Authors:  Leora Vegosen; Meghan F Davis; Ellen Silbergeld; Patrick N Breysse; Jacqueline Agnew; Gregory Gray; Laura Beane Freeman; Freya Kamel
Journal:  J Occup Environ Med       Date:  2012-10       Impact factor: 2.162

6.  Campylobacter jejuni-mediated induction of CC and CXC chemokines and chemokine receptors in human dendritic cells.

Authors:  Lan Hu; Mechelle D Bray; Yansheng Geng; Dennis J Kopecko
Journal:  Infect Immun       Date:  2012-06-11       Impact factor: 3.441

7.  Assessment of the duration of protection in Campylobacter jejuni experimental infection in humans.

Authors:  David R Tribble; Shahida Baqar; Daniel A Scott; Michael L Oplinger; Fernando Trespalacios; David Rollins; Richard I Walker; John D Clements; Steven Walz; Paul Gibbs; Edward F Burg; Anthony P Moran; Lisa Applebee; A Louis Bourgeois
Journal:  Infect Immun       Date:  2010-01-19       Impact factor: 3.441

Review 8.  Quantifying the association between Campylobacter infection and Guillain-Barré syndrome: a systematic review.

Authors:  Kate O Poropatich; Christa L Fischer Walker; Robert E Black
Journal:  J Health Popul Nutr       Date:  2010-12       Impact factor: 2.000

Review 9.  Guillain-Barré syndrome, transverse myelitis and infectious diseases.

Authors:  Yhojan Rodríguez; Manuel Rojas; Yovana Pacheco; Yeny Acosta-Ampudia; Carolina Ramírez-Santana; Diana M Monsalve; M Eric Gershwin; Juan-Manuel Anaya
Journal:  Cell Mol Immunol       Date:  2018-01-29       Impact factor: 11.530

10.  The epidemiology of Guillain-Barré Syndrome in U.S. military personnel: a case-control study.

Authors:  Laura Nelson; Robert Gormley; Mark S Riddle; David R Tribble; Chad K Porter
Journal:  BMC Res Notes       Date:  2009-08-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.